On 11 January, China Distance Education Holdings Limited (NYSE:DL) shares moved down -3.95% and was closed at $12.15. DL EPS growth in last 5 year was 40.02%. China Distance Education Holdings Limited (NYSE:DL) year to date (YTD) performance is -17.29%.
China Distance Education Holdings Limited (NYSE:DL) was downgraded by analysts at RBC Capital from a “sector perform” rating to an “underperform” rating in a note issued to investors on Thursday,StockTargetPrices.com reports. They currently have a €4.40 ($4.78) price target on the stock, down from their previous price target of €11.50 ($12.50).
Facebook Inc (NASDAQ:FB) shares advanced 0.18% in last trading session and ended the day at $97.51. FB Gross Margin is 83.10% and its has a return on assets of 6.50%. Facebook Inc (NASDAQ:FB) quarterly performance is 4.58%.
On 11 January, Facebook Inc (NASDAQ:FB) said that, it has become the only Internet firm to side with telecom operators over the issue of differential pricing of data services.
Alphabet Inc (NASDAQ:GOOG) caters to the Technology space. Its weekly performance is -3.48%. On the last day of trading company shares ended up at $716.03. Alphabet Inc (NASDAQ:GOOG) distance from 50-day simple moving average (SMA50) is -38.99%.
On 4 January, Alphabet Inc (NASDAQ:GOOG) disclosed that it paid $380.2 million to buy Bebop, the startup from VMware cofounder and former chief executive Diane Greene.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) shares moved down -9.54% in last trading session and ended the day at $3.51. KERX Gross Margin is 37.60% and its has a return on assets of -78.40%. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) quarterly performance is -17.41%.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) announced it presented at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11, 2016 at 9:30 a.m. PST (12:30 p.m. PST).
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) caters to the Healthcare space. Its weekly performance is -18.98%. On the last day of trading company shares ended up at $2.39. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) distance from 50-day simple moving average (SMA50) is 9.65%.
On 11 Jnauary, Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) announced that it has entered into a collaborative agreement with Hadassah Medical Center in Jerusalem, Israel, to conduct the planned multi dose Phase 2 trial with NurOwn® in Amyotrophic Lateral Sclerosis (ALS).
Leave a Reply